PCK1 Attenuates Tumor Stemness via Activating the Hippo Signaling Pathway in Hepatocellular Carcinoma

Researchers showed that phosphoenolpyruvate carboxylase 1 (PCK1) inhibited the self-renewal property of hepatoma cells, reduced the mRNA level of cancer stem cell markers, and inhibited tumorigenesis.